Literature DB >> 20025486

IgE-type multiple myeloma with the late development of IgA2 kappa and plasma cell leukaemia.

Weldon Chiu, Humphrey Pullon, See-Tarn Woon, Paul Oei, Roy The, Rohan Ameratunga.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20025486     DOI： 10.3109/00313020903434660

Source DB:  PubMed          Journal:  Pathology        ISSN： 0031-3025            Impact factor:   5.306


× No keyword cloud information.
  3 in total

1.  Bortezomib plus melphalan and prednisone (VMP regimen) as the initial treatment for IgE multiple myeloma: a case study.

Authors:  Hiroyuki Sato; Yusuke Komiya; Shigeru Hoshino
Journal:  Int J Hematol       Date:  2014-03-28       Impact factor: 2.490

2.  An unusual case of IgE-multiple myeloma presenting with systemic amyloidosis 2 years after cervical plasmacytoma resection.

Authors:  Masao Hagihara; Jian Hua; Morihiro Inoue; Naohiko Michikawa
Journal:  Int J Hematol       Date:  2010-08-10       Impact factor: 2.490

3.  Prozone effect of serum IgE levels in a case of plasma cell leukemia.

Authors:  Giampaolo Talamo; William Castellani; Nathan G Dolloff
Journal:  J Hematol Oncol       Date:  2010-09-10       Impact factor: 17.388
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.